title: Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates.
abstract: Due to inactivation of the α1,3-galactosyltransferase gene (GGTA1, or the α1,3GT gene) approximately 28 million years ago, the carbohydrate αGal (Galα1,3Galβ1,4GlcNAc) is not expressed on the cells of Old World monkeys and apes (including humans) but is expressed in all other mammals. The proposed selective advantage of this mutation for these primates is the ability to produce anti-Gal antibodies, which may be an effective immune component in neutralizing αGal-expressing pathogens. However, loss of α1,3GT expression may have been advantageous by providing natural resistance against viral pathogens that exploited the α1,3GT pathway or cell surface αGal for infection. Infections of paired cell lines with differential expression of α1,3GT showed that Sindbis viruses (SINV) preferentially replicate in α1,3GT-positive cells, whereas herpes simplex viruses type 1 and type 2 (HSV-1 and HSV-2) preferentially grow in cells lacking α1,3GT. Viral growth and spread correlated with the ability of the different viruses to successfully initiate infection in the presence or absence of α1,3GT expression. GT knockout (KO) suckling mice infected with SINV strains (AR339 and S.A.AR86) experienced significant delay in onset of disease symptoms and mortality compared to wild-type (WT) B6 suckling mice. In contrast, HSV-2-infected GT KO mice had higher viral titers in spleen and liver and exhibited significantly more focal hepatic necrosis than WT B6 mice. This study demonstrates that α1,3GT activity plays a role in the course of infections for certain viruses. Furthermore, this study has implications for the evolution of resistance to viral infections in primates.
authors.affiliation: Department of Anthropology, University of Massachusetts at Amherst, Amherst, Massachusetts, USA.
authors.forename: Idalia A
authors.initials: IA
authors.lastname: Rodriguez
authors.forename: Raymond M
authors.initials: RM
authors.lastname: Welsh
mesh_terms: D018354:Alphavirus Infections / Q000473:pathology / Q000821:virology; D000818:Animals; D002460:Cell Line; D002520:Cercopithecidae; D004195:Disease Models, Animal; D060467:Disease Resistance; D019143:Evolution, Molecular; D005260:Female; D005700:Galactosyltransferases / Q000235:genetics* / Q000378:metabolism; D017353:Gene Deletion; D006561:Herpes Simplex / Q000473:pathology / Q000821:virology; D018259:Herpesvirus 1, Human / Q000254:growth & development / Q000502:physiology; D018258:Herpesvirus 2, Human / Q000254:growth & development / Q000502:physiology; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D011991:Receptors, Virus / Q000235:genetics* / Q000378:metabolism; D012641:Selection, Genetic; D012845:Sindbis Virus / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology; D013154:Spleen / Q000473:pathology / Q000821:virology; D014777:Virus Diseases / Q000276:immunology*; D053586:Virus Internalization; D018406:Virus Physiological Phenomena
chemical_list: D011991:Receptors, Virus; D005700:Galactosyltransferases; C047006:N-acetyllactosaminide alpha-1,3-galactosyltransferase